The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

You may be eligible if

• Patients, aged 18 years or over, with histologically proven prostate cancer of all stages in whom endocrine treatment is indicated.
• Baseline testosterone \>1.5 ng/mL.
• Life expectancy of at least 12 months.